Summary:
- Innovent Biologics, a leading biopharmaceutical company, will present clinical data on multiple novel molecules at the upcoming 2023 American Association for Cancer Research (AACR) Annual Meeting.
- The data will include updates on the company's investigational treatments for various types of cancer, such as lung cancer, gastric cancer, and lymphoma.
- The presentations will showcase Innovent's commitment to developing innovative therapies and advancing the field of oncology research.